What is the recommended management for a pregnant woman with a secundum type atrial septal defect (ASD) and New York Heart Association (NYHA) class II symptoms at 40 5/7 weeks gestation in labor, considering beta blockers (e.g. metoprolol) or Lanoxin (digoxin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Secundum ASD, NYHA II, at Term in Labor

For a pregnant woman with secundum ASD and NYHA class II symptoms at 40 5/7 weeks in active labor, beta-blockers (specifically metoprolol or propranolol) are the recommended first-line agents for rate control if arrhythmias develop, while digoxin should be considered as second-line therapy if beta-blockers are ineffective or not tolerated. 1

Hemodynamic Considerations During Labor

  • Secundum ASD is generally well tolerated during pregnancy in the absence of severe pulmonary hypertension, though NYHA class II symptoms indicate some functional limitation that requires careful monitoring 1, 2
  • The hemodynamic stress of labor can precipitate arrhythmias (occurring in 4-5% of ASD patients), particularly supraventricular tachyarrhythmias, which are the most common cardiac complication in this population 2, 3
  • Pregnancy-related cardiovascular changes may paradoxically decrease left-to-right shunting (lower Qp/Qs ratio), though right ventricular strain increases 3

Medication Selection Algorithm

Beta-Blockers as First-Line Therapy

  • Beta-1 selective blockers (metoprolol, propranolol, labetalol) are recommended for rate control during pregnancy and labor, with the critical exception of atenolol, which should be avoided 1, 4
  • Atenolol is classified as Category D due to associations with intrauterine growth retardation and is contraindicated 4
  • Metoprolol and propranolol are FDA Category C and considered safe for use during labor with appropriate fetal monitoring 1
  • Beta-blockers effectively control heart rate in pregnant patients with structural heart disease and prevent arrhythmia-related hemodynamic deterioration 1

Digoxin (Lanoxin) as Second-Line Therapy

  • Digoxin should be considered for rate control if beta-blockers are ineffective or not tolerated during labor 1
  • Digoxin is FDA Category C and has extensive safety data in pregnancy 1
  • It provides effective rate control without the negative inotropic effects that could worsen right ventricular function in the setting of volume overload 1

Specific Management During Active Labor

Immediate Interventions if Arrhythmia Develops

  • If supraventricular tachycardia occurs, initiate vagal maneuvers first (Valsalva maneuver in supine position), followed by intravenous adenosine 6 mg rapid bolus if vagal maneuvers fail 1, 5
  • For sustained arrhythmias requiring rate control, administer intravenous metoprolol or propranolol as first-line agents 1
  • Synchronized cardioversion is recommended for hemodynamically unstable arrhythmias when pharmacological therapy fails 1

Monitoring Requirements

  • Continuous cardiac monitoring and pulse oximetry throughout labor to detect arrhythmias or right-to-left shunting 2, 6
  • Monitor for paradoxical emboli risk (occurs in 2-5% of ASD patients), particularly during Valsalva with pushing 2
  • Fetal heart rate monitoring is essential, as beta-blockers can reduce fetal heart rate variability through beta-1 selective blockade, though this is generally well-tolerated 4

Critical Pitfalls to Avoid

  • Never use atenolol - it has documented fetal risks including intrauterine growth retardation and is the only beta-blocker with Category D classification 4
  • Avoid aggressive volume loading, as this can worsen right ventricular volume overload and increase left-to-right shunting 3
  • Do not assume asymptomatic status based solely on oxygen saturation - "asymptomatic hypoxia" can occur with right-to-left shunting during labor 6
  • Avoid prolonged Valsalva during second stage if possible, as this increases risk of paradoxical embolism and can precipitate right-to-left shunting 2

Mode of Delivery Considerations

  • Vaginal delivery is preferred for most patients with secundum ASD and NYHA class II symptoms, as cesarean section increases bleeding risk without improving cardiac outcomes 1
  • Assisted second stage (forceps or vacuum) may be considered to minimize prolonged Valsalva and maternal effort 1
  • Epidural anesthesia is reasonable and preferred over general anesthesia, with precautions to avoid hypotension that could precipitate right-to-left shunting 1

Postpartum Vigilance

  • The immediate postpartum period (first 24-48 hours) carries increased risk for arrhythmias and hemodynamic decompensation due to autotransfusion from uterine involution 1
  • Continue cardiac monitoring for at least 24 hours postpartum 1
  • If beta-blockers or digoxin were initiated during labor, continue them postpartum with cardiology follow-up for potential discontinuation after hemodynamic stabilization 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Medications Affecting Fetal Heart Rate Variability

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Treatment for Supraventricular Tachycardia (SVT) in Pregnant Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.